M

MicroPort NeuroTech Ltd
HKEX:2172

Watchlist Manager
MicroPort NeuroTech Ltd
HKEX:2172
Watchlist
Price: 10.47 HKD -2.24% Market Closed
Market Cap: 6B HKD

MicroPort NeuroTech Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

MicroPort NeuroTech Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
M
MicroPort NeuroTech Ltd
HKEX:2172
Cash & Cash Equivalents
ÂĄ622.6m
CAGR 3-Years
2%
CAGR 5-Years
95%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash & Cash Equivalents
ÂĄ1.1B
CAGR 3-Years
52%
CAGR 5-Years
71%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash & Cash Equivalents
ÂĄ7.2B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
36%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash & Cash Equivalents
ÂĄ16.9B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash & Cash Equivalents
ÂĄ3.5B
CAGR 3-Years
-13%
CAGR 5-Years
4%
CAGR 10-Years
18%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash & Cash Equivalents
ÂĄ7.4B
CAGR 3-Years
37%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

MicroPort NeuroTech Ltd
Glance View

Market Cap
6B HKD
Industry
Health Care

MicroPort NeuroTech Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-07-15. MicroPort NeuroTech Ltd is a China-based investment holding company. The firm is principally engaged in the research and development, manufacturing and sales of neuro-interventional medical devices. The firm's main products include embolization coils, flow-diverting stents and stent grafts. The firm's products mainly cover three major areas of neurovascular diseases, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The firm mainly operates its businesses in the domestic and overseas markets.

Intrinsic Value
14.9 HKD
Undervaluation 30%
Intrinsic Value
Price
M

See Also

What is MicroPort NeuroTech Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
622.6m CNY

Based on the financial report for Dec 31, 2024, MicroPort NeuroTech Ltd's Cash & Cash Equivalents amounts to 622.6m CNY.

What is MicroPort NeuroTech Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
95%

Over the last year, the Cash & Cash Equivalents growth was -14%. The average annual Cash & Cash Equivalents growth rates for MicroPort NeuroTech Ltd have been 2% over the past three years , 95% over the past five years .

Back to Top